Seventure Partners

Type

Venture Capital

Status

Active

Location

Paris, France

Total investments

273

Average round size

12M

Portfolio companies

184

Rounds per year

10.11

Lead investments

73

Follow on index

0.32

Exits

51

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

Seventure Partners appeared to be the VC, which was created in 1997. The company was established in Europe in France. The main office of represented VC is situated in the Paris.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Seventure Partners, startups are often financed by Sofinnova Partners, Societe Generale Asset Management, Alven Capital. The meaningful sponsors for the fund in investment in the same round are XAnge, Sofinnova Partners, Omnes Capital. In the next rounds fund is usually obtained by Bpifrance, EASME - EU Executive Agency for SMEs, Auriga Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight DayTwo, Launchmetrics, BIOMx.

The fund is generally included in 7-12 deals every year. The increased amount of exits for fund were in 2016. The average startup value when the investment from Seventure Partners is 10-50 millions dollars. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Seventure Partners performs on 2 percentage points less the average number of lead investments.

We also calculated 12 valuable employees in our database.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistBiotech/Life SciencesFoodtechMedtechHealthcare Show 7 more
Stage focus
GeneralistSeed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 39 more
Check size
541K β€” 5M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 200000000
Fund raised date
2019-03-05

Analytics

Total investments
273
Lead investments
73
Exits
51
Rounds per year
10.11
Follow on index
0.32
Investments by industry
  • Biotechnology (102)
  • Health Care (67)
  • Software (55)
  • Therapeutics (31)
  • Medical (28)
  • Show 198 more
Investments by region
  • France (149)
  • United States (38)
  • Germany (40)
  • Denmark (9)
  • United Kingdom (11)
  • Show 11 more
Peak activity year
2020
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
8M
Group Appearance index
0.84
Avg. company exit year
10
Avg. multiplicator
1.00
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Allozymes 07 Aug 2023 Biotechnology, B2B Early Stage Venture 15M Central, Singapore, Singapore
YesWeHack 11 Jun 2024 Information Technology, Cyber Security, Security Late Stage Venture 30M Ile-de-France, Paris, France
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.